Feedback

Radiofluorination of an Anionic, Azide-Functionalized Teroligomer by Copper-Catalyzed Azide-Alkyne Cycloaddition

ORCID
0000-0001-7390-3575
Affiliation
Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany;(R.T.);(R.-P.M.);(T.H.L.);(K.K.);(P.B.)
Wenzel, Barbara;
ORCID
0000-0001-7250-1582
Affiliation
Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, 04317 Leipzig, Germany;(M.S.);(F.M.);(M.S.-S.)
Schmid, Maximilian;
Affiliation
Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany;(R.T.);(R.-P.M.);(T.H.L.);(K.K.);(P.B.)
Teodoro, Rodrigo;
ORCID
0000-0003-3119-7945
Affiliation
Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany;(R.T.);(R.-P.M.);(T.H.L.);(K.K.);(P.B.)
Moldovan, Rareş-Petru;
ORCID
0000-0001-8157-8979
Affiliation
Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany;(R.T.);(R.-P.M.);(T.H.L.);(K.K.);(P.B.)
Lai, Thu Hang;
Affiliation
Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, 04317 Leipzig, Germany;(M.S.);(F.M.);(M.S.-S.)
Mitrach, Franziska;
ORCID
0000-0003-4846-1271
Affiliation
Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany;(R.T.);(R.-P.M.);(T.H.L.);(K.K.);(P.B.)
Kopka, Klaus;
ORCID
0000-0002-2868-8754
Affiliation
Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany;
Fischer, Björn;
ORCID
0000-0003-1340-1850
Affiliation
Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, 04317 Leipzig, Germany;(M.S.);(F.M.);(M.S.-S.)
Schulz-Siegmund, Michaela;
ORCID
0000-0001-5555-7058
Affiliation
Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany;(R.T.);(R.-P.M.);(T.H.L.);(K.K.);(P.B.)
Brust, Peter;
ORCID
0000-0002-4776-2294
Affiliation
Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, 04317 Leipzig, Germany;(M.S.);(F.M.);(M.S.-S.)
Hacker, Michael C.

This study describes the synthesis, radiofluorination and purification of an anionic amphiphilic teroligomer developed as a stabilizer for siRNA-loaded calcium phosphate nanoparticles (CaP-NPs). As the stabilizing amphiphile accumulates on nanoparticle surfaces, the fluorine-18-labeled polymer should enable to track the distribution of the CaP-NPs in brain tumors by positron emission tomography after application by convection-enhanced delivery. At first, an unmodified teroligomer was synthesized with a number average molecular weight of 4550 ± 20 Da by free radical polymerization of a defined composition of methoxy-PEG-monomethacrylate, tetradecyl acrylate and maleic anhydride. Subsequent derivatization of anhydrides with azido-TEG-amine provided an azido-functionalized polymer precursor ( o14PEGMA-N 3 ) for radiofluorination. The 18 F-labeling was accomplished through the copper-catalyzed cycloaddition of o14PEGMA-N 3 with diethylene glycol–alkyne-substituted heteroaromatic prosthetic group [ 18 F]2, which was synthesized with a radiochemical yield (RCY) of about 38% within 60 min using a radiosynthesis module. The 18 F-labeled polymer [ 18 F]fluoro-o14PEGMA was obtained after a short reaction time of 2–3 min by using CuSO 4 /sodium ascorbate at 90 °C. Purification was performed by solid-phase extraction on an anion-exchange cartridge followed by size-exclusion chromatography to obtain [ 18 F]fluoro-o14PEGMA with a high radiochemical purity and an RCY of about 15%.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: © 2023 by the authors.

Use and reproduction: